The standard approach of assessing long-term risk for atherosclerotic cardiovascular disease (ASCVD) works just as well for patients who are
Assessing risk of heart disease no different for individuals with obesity
Home ยป
Experts outline key challenges for assessing clinical efficacy of COVID-19 vaccines
Collaboration and standardised approaches for assessing different vaccine efficacy endpoints are key for meaningful comparison of different COVID-19 vaccine candidates